BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 10384106)

  • 1. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors.
    Iñiguez MA; Punzón C; Fresno M
    J Immunol; 1999 Jul; 163(1):111-9. PubMed ID: 10384106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cyclooxygenase-2 expression by allergens in lymphocytes from allergic patients.
    Chacón P; Vega A; Monteseirín J; El Bekay R; Alba G; Pérez-Formoso JL; Msartínez A; Asturias JA; Pérez-Cano R; Sobrino F; Conde J
    Eur J Immunol; 2005 Aug; 35(8):2313-24. PubMed ID: 15997464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha.
    Barrios-Rodiles M; Tiraloche G; Chadee K
    J Immunol; 1999 Jul; 163(2):963-9. PubMed ID: 10395693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-gamma in human macrophages.
    Barrios-Rodiles M; Chadee K
    J Immunol; 1998 Sep; 161(5):2441-8. PubMed ID: 9725242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracrine upregulation of monocyte cyclooxygenase-2 by mediators produced by T lymphocytes: role of interleukin 17 and interferon-gamma.
    Stamp LK; James MJ; Cleland LG
    J Rheumatol; 2004 Jul; 31(7):1255-64. PubMed ID: 15229941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AgC10, a mucin from Trypanosoma cruzi, destabilizes TNF and cyclooxygenase-2 mRNA by inhibiting mitogen-activated protein kinase p38.
    Alcaide P; Fresno M
    Eur J Immunol; 2004 Jun; 34(6):1695-704. PubMed ID: 15162440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells.
    Efsen E; Bonacchi A; Pastacaldi S; Valente AJ; Wenzel UO; Tosti-Guerra C; Pinzani M; Laffi G; Abboud HE; Gentilini P; Marra F
    Hepatology; 2001 Mar; 33(3):713-21. PubMed ID: 11230753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta.
    Newton R; Kuitert LM; Bergmann M; Adcock IM; Barnes PJ
    Biochem Biophys Res Commun; 1997 Aug; 237(1):28-32. PubMed ID: 9266823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-independent inhibitory effects on T cell activation of novel 4,5-dihydro-3 trifluoromethyl pyrazole cyclooxygenase-2 inhibitors.
    Iñiguez MA; Punzón C; Cacheiro-Llaguno C; Díaz-Muñoz MD; Duque J; Cuberes R; Alvarez I; Andrés EM; Buxens J; Buschmann H; Vela JM; Fresno M
    Int Immunopharmacol; 2010 Oct; 10(10):1295-304. PubMed ID: 20709632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation.
    Michaluart P; Masferrer JL; Carothers AM; Subbaramaiah K; Zweifel BS; Koboldt C; Mestre JR; Grunberger D; Sacks PG; Tanabe T; Dannenberg AJ
    Cancer Res; 1999 May; 59(10):2347-52. PubMed ID: 10344742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells.
    Liu CY; Lai YY; Lo CJ
    J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is cyclooxygenase-2 important in skin carcinogenesis?
    Fischer SM
    J Environ Pathol Toxicol Oncol; 2002; 21(2):183-91. PubMed ID: 12086405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.
    Di Popolo A; Memoli A; Apicella A; Tuccillo C; di Palma A; Ricchi P; Acquaviva AM; Zarrilli R
    Oncogene; 2000 Nov; 19(48):5517-24. PubMed ID: 11114729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and tumor necrosis factor-alpha.
    Stamp LK; Cleland LG; James MJ
    J Rheumatol; 2004 Jul; 31(7):1246-54. PubMed ID: 15229940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N; Yamazaki R; Kawai S
    Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.